Therapeutic Potential of Apatinib Against Colorectal Cancer by Inhibiting VEGFR2-Mediated Angiogenesis and β-Catenin Signaling

PURPOSE: Apatinib is an inhibitor of VEGFR2 (vascular endothelial growth factor receptor 2) that has attracted a great deal of attention due to its promotion of anticancer activity. In the present study, we investigated the therapeutic effects of apatinib against colorectal cancer (CRC) and examined...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Onco Targets Ther
Hlavní autoři: Cai, Xiaomin, Wei, Bin, Li, Lele, Chen, Xiaofeng, Yang, Jing, Li, Xiaofei, Jiang, Xiaozheng, Lv, Mu, Li, Mingyang, Lin, Yumeng, Xu, Qiang, Guo, Wenjie, Gu, Yanhong
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7606303/
https://ncbi.nlm.nih.gov/pubmed/33154652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S266549
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky